TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/22 16:40 | 4/22/22 | VXRT | Vaxart, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tucker Sean | CA | O | SVP,Chie | M.d | 31 | 0.7700 | 0 | 40 | 27 | 188 | D | ||||||||||||||
8/11/21 18:53 | 8/10/21 | VXRT | Vaxart, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tucker Sean | CA | O | SVP,Chie | S | -102 | 10.20 | 0 | -10 | -9 | 104 | M | ||||||||||||||
3/19/21 17:04 | 3/16/21 | VXRT | Vaxart, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tucker Sean | CA | O | Chief Sc | M.d | 7 | 6.49 | 0 | 1 | 1 | 114 | D | ||||||||||||||
8/14/20 16:21 | 8/13/20 | VXRT | Vaxart, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tucker Sean | CA | O | Chief Sc | M.d | 26 | 6.49 | 0 | 4 | 4 | 113 | D | ||||||||||||||
4/12/19 18:04 | 4/11/19 | VXRT | Vaxart, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tucker Sean | CA | O | Chief Sc | P.d | 30 | 1.10 | 0 | 27 | 33 | 109 | I | ||||||||||||||
3/14/18 21:11 | 3/12/18 | VXRT | Vaxart, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Tucker Sean | CA | O | Chief Sc | M.d | 13 | 6.49 | 0 | 2 | 3 | 82 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |